Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corneal cells encompass the diverse cellular populations that make up the cornea, the clear front surface of the eye that acts as both a protective barrier and the primary refractive element for vision (NIH/NEI, 2023). The cornea consists of specialized layers: the outer epithelium, which provides a tight barrier; the stroma, containing keratocytes that maintain the extracellular matrix; and the inner endothelium, which regulates hydration to ensure transparency (StatPearls, 2023). As a therapeutic entity, "Corneal cells" is categorized as an incorrect target name because it represents a complex tissue rather than a specific molecule like a receptor or enzyme. However, these cells contain numerous specific targets for drug therapy, such as growth factor receptors involved in wound healing and inflammatory mediators associated with dry eye disease (PubMed, 2021). Ocular drugs typically aim to modulate the behavior of these cells to treat conditions such as keratitis, Fuchs' dystrophy, or corneal scarring. Monitoring these cells often involves assessing endothelial density or epithelial integrity to ensure drug safety and efficacy (Mayo Clinic, 2023).
Drugs targeting this tissue typically act on specific receptors or enzymes within the corneal layers (e.g., Nerve Growth Factor receptors or Integrins) to inhibit inflammation, promote nerve regeneration, or provide antimicrobial activity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal cells.